Literature DB >> 11751207

Overexpression of surfactant protein-C mature peptide causes neonatal lethality in transgenic mice.

Juliana Johnson Conkright1, Cheng-Lun Na, Timothy E Weaver.   

Abstract

Surfactant replacement preparations containing either surfactant protein (SP)-B or SP-C significantly improve lung function in surfactant-deficient infants, suggesting that these peptides may be functionally redundant. SP-B is absent and SP-C is greatly diminished in the airspaces of SP-B (-/-) mice, which die of respiratory distress syndrome (RDS) shortly after birth. The goal of this study was to determine if elevated expression of SP-C mature peptide could reverse the neonatal lethality in SP-B (-/-) mice. SP-C peptide (residues 24-57 of mouse SP-C proprotein) with a hemagglutinin epitope (SP-C(24-57)HA) was expressed in type II cells of transgenic mice, with the goal of crossing these animals into the SP-B (-/-) background. Unexpectedly, expression of the SP-C(24-57)HA transgene resulted in delayed/arrested lung development and lethal, neonatal RDS of all transgenic progeny in two independent transgenic lines. In transgenic mice, SP-C(24-57)HA was localized predominantly to the endoplasmic reticulum and Golgi; in contrast, SP-B and SP-C were very difficult to detect in the endoplasmic reticulum of wild-type mice. These results suggest that elevated expression of SP-C(24-57)HA in type II cells resulted in aggregation of SP-C in the early secretory pathway, leading to cytotoxicity and, ultimately, altered lung development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11751207     DOI: 10.1165/ajrcmb.26.1.4686

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  8 in total

1.  Clinical and ultrastructural spectrum of diffuse lung disease associated with surfactant protein C mutations.

Authors:  Donatella Peca; Renata Boldrini; Jan Johannson; Joseph T Shieh; Arianna Citti; Stefania Petrini; Teresa Salerno; Salvatore Cazzato; Raffaele Testa; Francesco Messina; Alfredo Onofri; Giovanna Cenacchi; Per Westermark; Nicola Ullmann; Nicola Ullman; Paola Cogo; Renato Cutrera; Olivier Danhaive
Journal:  Eur J Hum Genet       Date:  2015-03-18       Impact factor: 4.246

Review 2.  Endoplasmic reticulum stress in the pathogenesis of fibrotic disease.

Authors:  Jonathan A Kropski; Timothy S Blackwell
Journal:  J Clin Invest       Date:  2018-01-02       Impact factor: 14.808

3.  Lung injury and fibrosis induced by a mutant form of surfactant protein C.

Authors:  Timothy S Blackwell
Journal:  J Clin Invest       Date:  2018-08-13       Impact factor: 14.808

Review 4.  Human diseases of telomerase dysfunction: insights into tissue aging.

Authors:  Christine Kim Garcia; Woodring E Wright; Jerry W Shay
Journal:  Nucleic Acids Res       Date:  2007-10-02       Impact factor: 16.971

Review 5.  Transthyretin and BRICHOS: The Paradox of Amyloidogenic Proteins with Anti-Amyloidogenic Activity for Aβ in the Central Nervous System.

Authors:  Joel N Buxbaum; Jan Johansson
Journal:  Front Neurosci       Date:  2017-03-15       Impact factor: 4.677

Review 6.  Alveolar Dynamics and Beyond - The Importance of Surfactant Protein C and Cholesterol in Lung Homeostasis and Fibrosis.

Authors:  Kirsten Sehlmeyer; Jannik Ruwisch; Nuria Roldan; Elena Lopez-Rodriguez
Journal:  Front Physiol       Date:  2020-05-05       Impact factor: 4.566

Review 7.  The ER Stress/UPR Axis in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis.

Authors:  Mahmoud Aghaei; Sanaz Dastghaib; Sajjad Aftabi; Mohamad-Reza Aghanoori; Javad Alizadeh; Pooneh Mokarram; Parvaneh Mehrbod; Milad Ashrafizadeh; Ali Zarrabi; Kielan Darcy McAlinden; Mathew Suji Eapen; Sukhwinder Singh Sohal; Pawan Sharma; Amir A Zeki; Saeid Ghavami
Journal:  Life (Basel)       Date:  2020-12-22

Review 8.  Endogenous Human Proteins Interfering with Amyloid Formation.

Authors:  Anna L Gharibyan; Sanduni Wasana Jayaweera; Manuela Lehmann; Intissar Anan; Anders Olofsson
Journal:  Biomolecules       Date:  2022-03-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.